INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Dec 17, 2007 |
VP & Gn Mgr Ind Ops & Prod Sup
Trans History: 359
|
VP & Gn Mgr Ind Ops & Prod Sup | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,000 | -- | 40,000 |
Sep 07, 2007 |
VP & Gn Mgr Ind Ops & Prod Sup
Trans History: 359
|
VP & Gn Mgr Ind Ops & Prod Sup | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,136 | -- | 19,136 |
Sep 07, 2007 |
VP & Gn Mgr Ind Ops & Prod Sup
Trans History: 359
|
VP & Gn Mgr Ind Ops & Prod Sup | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,864 | -- | 60,864 |
Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,500 | $7.44 | 12,030 |
Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Open market or private sale of non-derivative or derivative security | 1,500 | $8.10 | 10,530 |
Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,500 | $7.44 | 12,030 |
Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Open market or private sale of non-derivative or derivative security | 1,500 | $7.96 | 10,530 |
Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,500 | $7.44 | 14,030 |
Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Open market or private sale of non-derivative or derivative security | 3,500 | $7.96 | 10,530 |
Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,000 | $7.44 | 18,530 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.